ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

45
ANTI-DOPING SEMINAR MFPA April 2013 David Attard

Transcript of ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Page 1: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

ANTI-DOPING SEMINAR

MFPA April 2013

David Attard

Page 2: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Summary• Doping - introduction• Prohibited list• Drug testing programme overview• Positive test results• Drug testing procedure• Therapeutic Use Exemptions• Clubs’ duties & responsibilities

Page 3: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

What is Doping?• Using a prohibited substance• Possessing a prohibited substance• Interfering with the testing process• Refusal to undergo test• Not providing whereabouts information (Out-of-

Competition). 3 missed tests/18 months for individuals in RTP

• Encouraging or assisting others to dope (including trafficking)

• Covering up Doping activities• Any type of complicity regarding doping activitiy

Page 4: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

IntroductionIn 1997, Sports Illustrated asked 198 aspiring US

Olympians,

“Would you take a banned performance enhancing substance if you were guaranteed to win and not get caught?”

98% said “YES”

Page 5: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

IntroductionThen, when asked,

“Would you take the same undetectable substance if it would contribute to winning every competition for 5 years, then result in death?”

Over 50% still said “YES!!!”

Page 6: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Why do performers take drugs?

PHYSIOLOGICAL REASONS

Lose weight, train harder

Mask injury and reduce

tiredness

To build muscle, increase energy

Increase oxygen

transport

Page 7: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Why do performers take drugs?

PSYCHOLOGICAL REASONS

To steady nerves

To increase aggression

To increase motivation

Page 8: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Why do performers take drugs?

SOCIAL REASONS

Pressure to win from coaches, peers and the media

By winning they can earn

big money

Fear of not winning

They are prepared to win

at all costs

Belief that everyone else

is doing it

Page 9: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Why shouldn’t they take drugs?

MORAL REASONS

LEGAL REASONS

•Gives an unfair advantage

•Undermines the true spirit of sport

•Reflects badly on others

•Against the law of the land

•Against the law of sports

Page 10: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Why shouldn’t they take drugs?

• Can be addictive• Lower life expectancy• Can cause death• Can lead to liver disorders and heart disease• Can suppress growth• Can cause sexual and gynaecological problems

• Can affect moods and behaviour causing aggression and depression

HEALTH REASONS

Page 11: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Why shouldn’t they take drugs?

ROLE MODELLING

•Gives a bad example to others, especially young

people who copy their heroes and put their lives

at risk

•Gives a bad image to sport and lowers its

status

Page 12: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Why fight Doping?

• Rules of the Game• Personal integrity• Anti-doping rules protect Athletes’ rights

Page 13: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Why is Doping dangerous?• Studies on substances for therapeutic reasons, not for

doping• Substances or methods used by athletes have been

developed for people with health problems• Athletes using Prohibited substances:• Are not always followed by a doctor• Often take larger doses• Might use in combination with other substances

• Are often illegal or counterfeit substances that are not regulated

Page 14: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

How does a substance become prohibited?

What are the criteria for adding a substance to the List?

Must meet any 2 of the following 3 criteria:

It has the potential to enhance or enhances sport performance;

It represents an actual or potential health risk to the athlete;

It violates the Spirit of Sport.

Page 15: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Drugs in Sport

1. Socially acceptable: alcohol, nicotine, - NOT PROHIBITED

2. Medications: OTC and prescribed drugs – MAY BE PROHIBITED

3. Socially unacceptable: Marijuana, cocaine, ecstasy, etc.

4. Performance enhancers

5. Contaminated supplements

Page 16: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Common medications• There are some common medications on the Prohibited

List.  An athlete or a medical professional should not make assumptions regarding the status of any medications. 

• It is the responsibility of the athlete to ensure that all medical professionals are aware of their status as an athlete who could be tested. All athletes should ask medical professionals to check the status of medications during the prescription process and when purchasing medications over the counter at a pharmacy.

Page 17: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

The World Anti-Doping Code

THE 2013PROHIBITED LIST

INTERNATIONAL

STANDARD

The official text of the Prohibited List shall be maintained by WADA and shall be

published in English and French. In the event of any conflict between the English

and French versions, the English version shall prevail.

This List came into effect on 1 January 2013The Prohibited list is a document which identifies the substances and methods prohibited in-competition, out-of-competition, and in particular sports

Page 18: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

PROHIBITED SUBSTANCESS.1. Anabolic agents

1.a. Exogenous AAS (boldenone, nandrolone, mibolerone, ... and related substances1.b. Endogenous AAS2. Other anabolic agents (clenbuterol)

S.2. Hormones and related substances (hCG, hGH, ACTH, EPO, … and releasing factors) S.3. b-2 AgonistsS.4. Agents with anti-estrogenic activity (aromatase inhibitors, SERMs)S.5. Diuretics and masking agents (amilioride, ethacrynic acid, spironolactone, ... and related compounds)

S.6. Stimulants (amphetamine, cocaine, mesocarb, strychnine, ... and related compounds)

PROHIBITED SUBSTANCESS.1. Anabolic agents

1.a. Exogenous AAS (boldenone, nandrolone, mibolerone, ... and related substances1.b. Endogenous AAS2. Other anabolic agents (clenbuterol)

S.2. Hormones and related substances (hCG, hGH, ACTH, EPO, … and releasing factors) S.3. b-2 AgonistsS.4. Agents with anti-estrogenic activity (aromatase inhibitors, SERMs)S.5. Diuretics and masking agents (amilioride, ethacrynic acid, spironolactone, ... and related compounds)

S.6. Stimulants (amphetamine, cocaine, mesocarb, strychnine, ... and related compounds)

S.7. Narcotics(buprenorphine, levorphanol, meperidine, …)S.8. CannabinoidsS.9. Glucocorticoids

PROHIBITED METHODSM.1. Enhancement of O2 transferM.2. Chemical or Physical ManipulationM.3. Gene Doping

USE LIMITED IN SPECIFIC SPORTSP.1. AlcoholP.2. -blockers (acebutolol, atenolol, sotalol, ... and related compounds)

S.7. Narcotics(buprenorphine, levorphanol, meperidine, …)S.8. CannabinoidsS.9. Glucocorticoids

PROHIBITED METHODSM.1. Enhancement of O2 transferM.2. Chemical or Physical ManipulationM.3. Gene Doping

USE LIMITED IN SPECIFIC SPORTSP.1. AlcoholP.2. -blockers (acebutolol, atenolol, sotalol, ... and related compounds)

Page 19: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Anabolic Agents• Enhance muscle mass gained from strength training

- Anabolic steriods

- Testosterone precursors

Page 20: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Anabolic Steroids

• Testosterone derivatives – modified to increase anabolic effects while decreasing androgenic effects

• Doses may reach 100X medical replacement dose• Efficacy in numerous studies since the 1970’s

Page 21: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Anabolic steroid side effects

• Acne• Alopecia• Testicular atrophy• Masculinization• Gynecomastia• Infertility• Mood alterations

• Adverse lipid profile• Hypertension• Glucose intolerance• Premature epiphyseal closure

Page 22: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Human Growth Hormone

• Manufactured by recombinant technology for replacement in deficient patients

• Promotes protein anabolism• Intramuscular delivery• No virilizing effects – attractive to women

Page 23: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Human Growth Hormone

• Studies suggest increases in muscle size, but not strength (increased collagen in muscles without an increase in contractile tissue)

• Excess may lead to SxS of acromegaly

Page 24: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Stimulants• Promote CNS and muscular excitation• Caffeine (not prohibited)• Amphetamines• Ephedrine (and pseudoephedrine)

Page 25: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Pseudo-ephedrine• Pseudoephedrine is an ingredient in many cold, flu and

sinus remedies • Consider using an alternative medication. There are several

products that contain phenylehphrine instead, which is permitted in sport.

• Never exceed the manufacturers recommended dose.• Do not use any medications that contain pseudoephedrine with 24

hours (minimum) of competing.

Page 26: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Specified substances• A specified substance is a substance which allows, under

defined conditions, for a greater reduction of a two-year sanction when an athlete tests positive for that particular substance.

• The purpose is to recognize that it is possible for a substance to enter an athlete’s body inadvertently, and therefore allow a tribunal more flexibility when making a sanctioning decision.

• Eg: Ephedrine, Pseudoephedrine, etc.• Non-specified: Cocaine, Amphetamine, Anabolic Steroids,

HGH, etc.

Page 27: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Herbal products• Some herbal products contain banned substances. For

example, the plant Ma Huang (Chinese Ephedra) contains the banned drug ephedrine. Therefore, products containing Ma Huang are banned. Extreme caution should be taken when using nutritional supplements and/or herbal products as they may contain banned substances not shown in the list of ingredients. 

Page 28: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Hair loss products• Finasteride: a substance contained in particular in a

number of hair loss treatments (Propecia). • It was added to the List in 2005 (in- and out-of

competition) following compelling research showing that they could mask steroids in the doping control process.

• Removed from banned list in 2009 due to advances in steroid profile assays

Page 29: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

ED • Sildenafil, aka: Viagra• Not banned• Under study as alleged enhancement of athletic

performance, especially at altitude.

Page 30: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Intravenous infusions (IVI)• An IV infusion is the supply of fluids or other liquid

substrates through a vein; achieved by inserting a specialized needle into a vein and infusing fluids at a predetermined rate from a reservoir.

• Since 2005, intravenous (IV) infusions have been included in the WADA list of prohibited substances and methods under Section M2.Prohibited Methods,

• Chemical and Physical Manipulation and are prohibited both in and out-of-competition.

• The current wording (2009) states that “Intravenous infusions are prohibited except in the management of surgical procedures, medical emergencies or clinical investigations.”

Page 31: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Bottom line• Check medications!• Competent personnel, literature, websites.

• www.globaldro.co.uk• Medications bought in one country may contain

different ingredients in another country

Beware of Supplements!

Page 32: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Supplements• Supplements can present a high risk for several reasons:

• They do not fall under the same regulations as food and medicines. This means they do not have to state all their ingredients on the label, so you may not know what you’re taking

• Advertising of supplements can suggest untested claims about their benefits

• Production of some supplements has low quality control, which means that there is a chance of contamination with other products that may be banned substances.

• Diet, lifestyle and training should all be optimised before considering supplements. • Athletes should assess the need for supplements by consulting an

accredited sports dietician, registered nutritionist with expertise in sports nutrition, or a sports and exercise medicine doctor, before taking supplements.

Page 33: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Key Concepts• Performance enhancement is not limited to adding muscle

• Recovery (steroids)• Euphoric feelings; improved focus and concentration; alteration of the perception of

fatigue (stimulants)• Improved vision (hGH)

• What is considered a “side-effect” medically may be the desired effect for performance-enhancement (example - pseudoephedrine)

• It is difficult (or impossible) ethically to conduct research at the doses and combinations of substances that could be used for performance-enhancement (example – androstenedione in children)

• It is the effect of a substance, not the source, that is important (example - “natural” dietary supplements)

Page 34: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

MFA antidoping - Positive results (to date) included the following substances:

• Pseudoephedrine • Ephedrine• Salbutamol (without TUE, in the previous list)• Methylenedioxymethamphetamine (MDMA – Ecstacy)• Ephedrine • Cocaine• Androstenedione• Nandrolone• Stanozolol• Clenbuterol• Testosterone (physiological causes)• Cannabinoids (marijuana)• Prednisolone (without TUE)• Methylhexanamine

Page 35: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Comments

• Strict liability principle• More testing….. ?• Increasing abuse of social drugs• Misconceptions & misperceptions of doping control by players / clubs

• Failure to comply with regulations• Inadequate Medical control of drug consumption by players

• Supplement contamination

Page 36: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Drug testing procedure

• Urine sample is split into two collection bottles (A & B) and these are sealed.

• Players are given an ID no. and sign respective forms.

• Samples dispatched to accredited WADA lab to be analysed

Page 37: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Results• If negative – no further steps.• If positive – player/club notified

Page 38: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Next steps• B test offered.• If still positive – case examined by Medical Commission• Report passed on to Executive Committee and relevant

disciplinary board• Immediate suspension pending investigation (with

exceptions)

Page 39: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Therapeutic Use Exemptions• Athletes, like all others, may have illnesses or

conditions that require them to take particular medications.

• If the medication an athlete is required to take to treat an illness or condition happens to fall under the Prohibited List, a Therapeutic Use Exemption may give that athlete the authorization to take the needed medicine.

Page 40: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Therapeutic Use Exemptions

•STANDARD FORM

Page 41: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.
Page 42: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

What are the criteria for granting a TUE?

The criteria are:• The athlete would experience significant health problems without taking the prohibited substance or method,

• The therapeutic use of the substance would not produce significant enhancement of performance, and

• There is no reasonable therapeutic alternative to the use of the otherwise prohibited substance or method.

Page 43: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Standard form

• For any treatment involving a substance or method on the Prohibited List.

• If approved, athlete can begin treatment only after receiving the authorization notice from the relevant organization (except in rare cases of an acute life threatening condition for which a retroactive approval may be considered).

Page 44: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.

Clubs’ duties and responsibilities• Education of players• Responsibility for players’ health & safety• Close liaison with Medical Officer• To keep up to date with procedures and revised lists• Proper filling in of the right forms• TUE forms• Code of conduct during testing• Role definition re-doping matters in each club• ? Club policy/procedure re - Social Drug Abuse by players

Page 45: ANTI-DOPING SEMINAR MFPA April 2013 David Attard.